APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Domperidone Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Domperidone Tablets Market Outlook and Growth Opportunities 2026

Report ID 173985590429 December 2025191 pages

Choose your research edition.

Industry ResearchDomperidone Tablets Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Domperidone Tablets Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Domperidone Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Domperidone Tablets Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Domperidone Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Domperidone Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Domperidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Domperidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Domperidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Domperidone Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Domperidone Tablets market include Foshan Chiral Pharmaceutical, Hansoh Pharmaceutical, Livzon Pharmaceutical, Weiao Pharmaceutical, Changzhou Pharmaceutical Factory, Johnson & Johnson and Shanghai Sine Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Domperidone Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Domperidone Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Domperidone Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Domperidone Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Domperidone Tablets Segment by Company

Foshan Chiral Pharmaceutical

Hansoh Pharmaceutical

Livzon Pharmaceutical

Weiao Pharmaceutical

Changzhou Pharmaceutical Factory

Johnson & Johnson

Shanghai Sine Pharmaceutical

Domperidone Tablets Segment by Type

Original Drug

Generic Drug

Domperidone Tablets Segment by Application

Hospital and Clinic

Pharmacy

Domperidone Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Domperidone Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Domperidone Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Domperidone Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Domperidone Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Domperidone Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Domperidone Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Domperidone Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Domperidone Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Domperidone Tablets industry.

Chapter 3: Detailed analysis of Domperidone Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Domperidone Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Domperidone Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Domperidone Tablets Industry Trends Table 2. Domperidone Tablets Industry Drivers Table 3. Domperidone Tablets Industry Opportunities and Challenges Table 4. Domperidone Tablets Industry Restraints Table 5. Global Domperidone Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Domperidone Tablets Revenue Share by Company (2021-2026) Table 7. Global Domperidone Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Domperidone Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Domperidone Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Domperidone Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Domperidone Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Domperidone Tablets Company, Product Type & Application Table 13. Global Domperidone Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Domperidone Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Domperidone Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Domperidone Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Domperidone Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Domperidone Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Domperidone Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Domperidone Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Domperidone Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Domperidone Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Domperidone Tablets Sales Value Share by Type (2021-2026) Table 28. Global Domperidone Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Global Domperidone Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Domperidone Tablets Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Domperidone Tablets Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Domperidone Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Domperidone Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Domperidone Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Domperidone Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Domperidone Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Domperidone Tablets Sales Value Share by Application (2021-2026) Table 40. Global Domperidone Tablets Sales Value Share by Application (2027-2032) Table 41. Global Domperidone Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Domperidone Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Domperidone Tablets Sales Market Share by Region (2021-2026) Table 44. Global Domperidone Tablets Sales by Region (2027-2032) & (K Units) Table 45. Global Domperidone Tablets Sales Market Share by Region (2027-2032) Table 46. Global Domperidone Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Domperidone Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Domperidone Tablets Sales Value Share by Region (2021-2026) Table 49. Global Domperidone Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Domperidone Tablets Sales Value Share by Region (2027-2032) Table 51. Global Domperidone Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Domperidone Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Domperidone Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Domperidone Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Domperidone Tablets Sales by Country (2021-2026) & (K Units) Table 56. Global Domperidone Tablets Sales Market Share by Country (2021-2026) Table 57. Global Domperidone Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Domperidone Tablets Sales Market Share by Country (2027-2032) Table 59. Global Domperidone Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Domperidone Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Domperidone Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Domperidone Tablets Sales Value Market Share by Country (2027-2032) Table 63. Foshan Chiral Pharmaceutical Company Information Table 64. Foshan Chiral Pharmaceutical Business Overview Table 65. Foshan Chiral Pharmaceutical Domperidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Foshan Chiral Pharmaceutical Domperidone Tablets Product Portfolio Table 67. Foshan Chiral Pharmaceutical Recent Development Table 68. Hansoh Pharmaceutical Company Information Table 69. Hansoh Pharmaceutical Business Overview Table 70. Hansoh Pharmaceutical Domperidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hansoh Pharmaceutical Domperidone Tablets Product Portfolio Table 72. Hansoh Pharmaceutical Recent Development Table 73. Livzon Pharmaceutical Company Information Table 74. Livzon Pharmaceutical Business Overview Table 75. Livzon Pharmaceutical Domperidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Livzon Pharmaceutical Domperidone Tablets Product Portfolio Table 77. Livzon Pharmaceutical Recent Development Table 78. Weiao Pharmaceutical Company Information Table 79. Weiao Pharmaceutical Business Overview Table 80. Weiao Pharmaceutical Domperidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Weiao Pharmaceutical Domperidone Tablets Product Portfolio Table 82. Weiao Pharmaceutical Recent Development Table 83. Changzhou Pharmaceutical Factory Company Information Table 84. Changzhou Pharmaceutical Factory Business Overview Table 85. Changzhou Pharmaceutical Factory Domperidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Changzhou Pharmaceutical Factory Domperidone Tablets Product Portfolio Table 87. Changzhou Pharmaceutical Factory Recent Development Table 88. Johnson & Johnson Company Information Table 89. Johnson & Johnson Business Overview Table 90. Johnson & Johnson Domperidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Johnson & Johnson Domperidone Tablets Product Portfolio Table 92. Johnson & Johnson Recent Development Table 93. Shanghai Sine Pharmaceutical Company Information Table 94. Shanghai Sine Pharmaceutical Business Overview Table 95. Shanghai Sine Pharmaceutical Domperidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Shanghai Sine Pharmaceutical Domperidone Tablets Product Portfolio Table 97. Shanghai Sine Pharmaceutical Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Domperidone Tablets Distributors List Table 101. Domperidone Tablets Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Domperidone Tablets Product Image Figure 2. Global Domperidone Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Domperidone Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Domperidone Tablets Sales (2021-2032) & (K Units) Figure 5. Global Domperidone Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Domperidone Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Domperidone Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Domperidone Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Domperidone Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Domperidone Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Domperidone Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Domperidone Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Global Domperidone Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Domperidone Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Domperidone Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Domperidone Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Domperidone Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Domperidone Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Domperidone Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Domperidone Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Domperidone Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Domperidone Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Domperidone Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Domperidone Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Domperidone Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Domperidone Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Domperidone Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Domperidone Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Domperidone Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Domperidone Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Domperidone Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Domperidone Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Domperidone Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Domperidone Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Domperidone Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Domperidone Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Domperidone Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • Foshan Chiral Pharmaceutical
  • Hansoh Pharmaceutical
  • Livzon Pharmaceutical
  • Weiao Pharmaceutical
  • Changzhou Pharmaceutical Factory
  • Johnson & Johnson
  • Shanghai Sine Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Domperidone Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Domperidone Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Domperidone Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Domperidone Tablets Market Dynamics
  1. 2.1 Domperidone Tablets Industry Trends
  2. 2.2 Domperidone Tablets Industry Drivers
  3. 2.3 Domperidone Tablets Industry Opportunities and Challenges
  4. 2.4 Domperidone Tablets Industry Restraints
3 Domperidone Tablets Market by Company
  1. 3.1 Global Domperidone Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Domperidone Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Domperidone Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Domperidone Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Domperidone Tablets Company Ranking (2024-2026)
  6. 3.6 Global Domperidone Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Domperidone Tablets Company Product Type and Application
  8. 3.8 Global Domperidone Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Domperidone Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Domperidone Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Domperidone Tablets Market by Type
  1. 4.1 Domperidone Tablets Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Domperidone Tablets Sales Volume by Type
  5. 4.2.1 Global Domperidone Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Domperidone Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Domperidone Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Domperidone Tablets Sales Value by Type
  9. 4.3.1 Global Domperidone Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Domperidone Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Domperidone Tablets Sales Value Share by Type (2021-2032)
5 Domperidone Tablets Market by Application
  1. 5.1 Domperidone Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.2 Global Domperidone Tablets Sales Volume by Application
  5. 5.2.1 Global Domperidone Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Domperidone Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Domperidone Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Domperidone Tablets Sales Value by Application
  9. 5.3.1 Global Domperidone Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Domperidone Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Domperidone Tablets Sales Value Share by Application (2021-2032)
6 Domperidone Tablets Regional Sales and Value Analysis
  1. 6.1 Global Domperidone Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Domperidone Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Domperidone Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Domperidone Tablets Sales by Region (2027-2032)
  5. 6.3 Global Domperidone Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Domperidone Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Domperidone Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Domperidone Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Domperidone Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Domperidone Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Domperidone Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Domperidone Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Domperidone Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Domperidone Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Domperidone Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Domperidone Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Domperidone Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Domperidone Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Domperidone Tablets Sales Value Share by Country, 2025 VS 2032
7 Domperidone Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Domperidone Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Domperidone Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Domperidone Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Domperidone Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Domperidone Tablets Sales by Country (2027-2032)
  6. 7.4 Global Domperidone Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Domperidone Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Domperidone Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Domperidone Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Domperidone Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Domperidone Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Domperidone Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Domperidone Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Domperidone Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Domperidone Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Domperidone Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Domperidone Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Domperidone Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Domperidone Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Domperidone Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Domperidone Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Domperidone Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Domperidone Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Domperidone Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Domperidone Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Domperidone Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Domperidone Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Domperidone Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Domperidone Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Domperidone Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Domperidone Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Domperidone Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Domperidone Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Domperidone Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Domperidone Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Domperidone Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Domperidone Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Domperidone Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Foshan Chiral Pharmaceutical
  2. 8.1.1 Foshan Chiral Pharmaceutical Company Information
  3. 8.1.2 Foshan Chiral Pharmaceutical Business Overview
  4. 8.1.3 Foshan Chiral Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Foshan Chiral Pharmaceutical Domperidone Tablets Product Portfolio
  6. 8.1.5 Foshan Chiral Pharmaceutical Recent Developments
  7. 8.2 Hansoh Pharmaceutical
  8. 8.2.1 Hansoh Pharmaceutical Company Information
  9. 8.2.2 Hansoh Pharmaceutical Business Overview
  10. 8.2.3 Hansoh Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hansoh Pharmaceutical Domperidone Tablets Product Portfolio
  12. 8.2.5 Hansoh Pharmaceutical Recent Developments
  13. 8.3 Livzon Pharmaceutical
  14. 8.3.1 Livzon Pharmaceutical Company Information
  15. 8.3.2 Livzon Pharmaceutical Business Overview
  16. 8.3.3 Livzon Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Livzon Pharmaceutical Domperidone Tablets Product Portfolio
  18. 8.3.5 Livzon Pharmaceutical Recent Developments
  19. 8.4 Weiao Pharmaceutical
  20. 8.4.1 Weiao Pharmaceutical Company Information
  21. 8.4.2 Weiao Pharmaceutical Business Overview
  22. 8.4.3 Weiao Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Weiao Pharmaceutical Domperidone Tablets Product Portfolio
  24. 8.4.5 Weiao Pharmaceutical Recent Developments
  25. 8.5 Changzhou Pharmaceutical Factory
  26. 8.5.1 Changzhou Pharmaceutical Factory Company Information
  27. 8.5.2 Changzhou Pharmaceutical Factory Business Overview
  28. 8.5.3 Changzhou Pharmaceutical Factory Domperidone Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou Pharmaceutical Factory Domperidone Tablets Product Portfolio
  30. 8.5.5 Changzhou Pharmaceutical Factory Recent Developments
  31. 8.6 Johnson & Johnson
  32. 8.6.1 Johnson & Johnson Company Information
  33. 8.6.2 Johnson & Johnson Business Overview
  34. 8.6.3 Johnson & Johnson Domperidone Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Johnson & Johnson Domperidone Tablets Product Portfolio
  36. 8.6.5 Johnson & Johnson Recent Developments
  37. 8.7 Shanghai Sine Pharmaceutical
  38. 8.7.1 Shanghai Sine Pharmaceutical Company Information
  39. 8.7.2 Shanghai Sine Pharmaceutical Business Overview
  40. 8.7.3 Shanghai Sine Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Sine Pharmaceutical Domperidone Tablets Product Portfolio
  42. 8.7.5 Shanghai Sine Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Domperidone Tablets Value Chain Analysis
  2. 9.1.1 Domperidone Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Domperidone Tablets Sales Mode & Process
  6. 9.2 Domperidone Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Domperidone Tablets Distributors
  9. 9.2.3 Domperidone Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst